Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1985 Dec;38(12):1353–1357. doi: 10.1136/jcp.38.12.1353

An immunocytochemical study of malignant melanoma and its differential diagnosis from other malignant tumours.

K C Gatter, E Ralfkiaer, J Skinner, D Brown, A Heryet, K A Pulford, K Hou-Jensen, D Y Mason
PMCID: PMC499492  PMID: 3908491

Abstract

A series of 41 fresh and 36 routinely processed malignant melanomas were immunostained with a panel of 12 monoclonal antibodies reactive against a range of epithelial, lymphoid, and melanoma associated antigens. The aim of the study was to determine whether this panel of antibodies would be useful in diagnostically difficult cases for differentiating melanomas from other tumours, particularly carcinomas and lymphomas. The results confirmed that most unequivocal malignant melanomas can be identified by positivity for S100 protein and for the antigen recognised by antibody NK1/C3, and by negativity for epithelial and lymphoid antigens. The incidence of melanomas expressing cytokeratin antigens was higher, however, particularly in cryostat sections than has previously been reported. It is therefore suggested that a panel of antibodies with more than one marker in each category should be used for identifying melanomas in clinical practice.

Full text

PDF
1356

Images in this article

1354Image
on p.1354

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Altmannsberger M., Osborn M., Schauer A., Weber K. Antibodies to different intermediate filament proteins. Cell type-specific markers on paraffin-embedded human tissues. Lab Invest. 1981 Nov;45(5):427–434. [PubMed] [Google Scholar]
  2. Cordell J. L., Falini B., Erber W. N., Ghosh A. K., Abdulaziz Z., MacDonald S., Pulford K. A., Stein H., Mason D. Y. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem. 1984 Feb;32(2):219–229. doi: 10.1177/32.2.6198355. [DOI] [PubMed] [Google Scholar]
  3. Debus E., Moll R., Franke W. W., Weber K., Osborn M. Immunohistochemical distinction of human carcinomas by cytokeratin typing with monoclonal antibodies. Am J Pathol. 1984 Jan;114(1):121–130. [PMC free article] [PubMed] [Google Scholar]
  4. Gabbiani G., Kapanci Y., Barazzone P., Franke W. W. Immunochemical identification of intermediate-sized filaments in human neoplastic cells. A diagnostic aid for the surgical pathologist. Am J Pathol. 1981 Sep;104(3):206–216. [PMC free article] [PubMed] [Google Scholar]
  5. Gatter K. C., Abdulaziz Z., Beverley P., Corvalan J. R., Ford C., Lane E. B., Mota M., Nash J. R., Pulford K., Stein H. Use of monoclonal antibodies for the histopathological diagnosis of human malignancy. J Clin Pathol. 1982 Nov;35(11):1253–1267. doi: 10.1136/jcp.35.11.1253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Gatter K. C., Alcock C., Heryet A., Mason D. Y. Clinical importance of analysing malignant tumours of uncertain origin with immunohistological techniques. Lancet. 1985 Jun 8;1(8441):1302–1305. doi: 10.1016/s0140-6736(85)92794-1. [DOI] [PubMed] [Google Scholar]
  7. Gatter K. C., Alcock C., Heryet A., Pulford K. A., Heyderman E., Taylor-Papadimitriou J., Stein H., Mason D. Y. The differential diagnosis of routinely processed anaplastic tumors using monoclonal antibodies. Am J Clin Pathol. 1984 Jul;82(1):33–43. doi: 10.1093/ajcp/82.1.33. [DOI] [PubMed] [Google Scholar]
  8. Gatter K. C., Pulford K. A., Vanstapel M. J., Roach B., Mortimer P., Woolston R. E., Taylor-Papadimitriou J., Lane E. B., Mason D. Y. An immunohistological study of benign and malignant skin tumours: epithelial aspects. Histopathology. 1984 Mar;8(2):209–227. doi: 10.1111/j.1365-2559.1984.tb02337.x. [DOI] [PubMed] [Google Scholar]
  9. Janossy G., Thomas J. A., Pizzolo G., Granger S. M., McLaughlin J., Habeshaw J. A., Stansfeld A. G., Sloane J. Immuno-histological diagnosis of lymphoproliferative diseases by selected combinations of antisera and monoclonal antibodies. Br J Cancer. 1980 Aug;42(2):224–242. doi: 10.1038/bjc.1980.222. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Lauder I., Holland D., Mason D. Y., Gowland G., Cunliffe W. J. Identification of large cell undifferentiated tumours in lymph nodes using leucocyte common and keratin antibodies. Histopathology. 1984 Mar;8(2):259–272. doi: 10.1111/j.1365-2559.1984.tb02340.x. [DOI] [PubMed] [Google Scholar]
  11. Mackie R. M., Campbell I., Turbitt M. L. Use of NK1 C3 monoclonal antibody in the assessment of benign and malignant melanocytic lesions. J Clin Pathol. 1984 Apr;37(4):367–372. doi: 10.1136/jcp.37.4.367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Makin C. A., Bobrow L. G., Bodmer W. F. Monoclonal antibody to cytokeratin for use in routine histopathology. J Clin Pathol. 1984 Sep;37(9):975–983. doi: 10.1136/jcp.37.9.975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Nagle R. B., McDaniel K. M., Clark V. A., Payne C. M. The use of antikeratin antibodies in the diagnosis of human neoplasms. Am J Clin Pathol. 1983 Apr;79(4):458–466. doi: 10.1093/ajcp/79.4.458. [DOI] [PubMed] [Google Scholar]
  14. Nakajima T., Watanabe S., Sato Y., Kameya T., Shimosato Y., Ishihara K. Immunohistochemical demonstration of S100 protein in malignant melanoma and pigmented nevus, and its diagnostic application. Cancer. 1982 Sep 1;50(5):912–918. doi: 10.1002/1097-0142(19820901)50:5<912::aid-cncr2820500519>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  15. Pizzolo G., Sloane J., Beverley P., Thomas J. A., Bradstock K. F., Mattingly S., Janossy G. Differential diagnosis of malignant lymphoma and nonlymphoid tumors using monoclonal anti-leucocyte antibody. Cancer. 1980 Dec 15;46(12):2640–2647. doi: 10.1002/1097-0142(19801215)46:12<2640::aid-cncr2820461218>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  16. Ramaekers F. C., Puts J. J., Moesker O., Kant A., Vooijs G. P., Jap P. H. Intermediate filaments in malignant melanomas. Identification and use as marker in surgical pathology. J Clin Invest. 1983 Mar;71(3):635–643. doi: 10.1172/JCI110810. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Sloane J. P., Ormerod M. G. Distribution of epithelial membrane antigen in normal and neoplastic tissues and it value in diagnostic tumor pathology. Cancer. 1981 Apr 1;47(7):1786–1795. doi: 10.1002/1097-0142(19810401)47:7<1786::aid-cncr2820470711>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  18. Vanstapel M. J., Peeters B., Cordell J., Heyns W., De Wolf-Peeters C., Desmet V., Mason D. Production of monoclonal antibodies directed against antigenic determinants common to the alpha- and beta-chain of bovine brain S-100 protein. Lab Invest. 1985 Feb;52(2):232–238. [PubMed] [Google Scholar]
  19. Viac J., Reano A., Brochier J., Staquet M. J., Thivolet J. Reactivity pattern of a monoclonal antikeratin antibody (KL1). J Invest Dermatol. 1983 Oct;81(4):351–354. doi: 10.1111/1523-1747.ep12519941. [DOI] [PubMed] [Google Scholar]
  20. van Duinen S. G., Ruiter D. J., Hageman P., Vennegoor C., Dickersin G. R., Scheffer E., Rümke P. Immunohistochemical and histochemical tools in the diagnosis of amelanotic melanoma. Cancer. 1984 Apr 1;53(7):1566–1573. doi: 10.1002/1097-0142(19840401)53:7<1566::aid-cncr2820530724>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  21. van Muijen G. N., Ruiter D. J., Ponec M., Huiskens-van der, Mey C., Warnaar S. O. Monoclonal antibodies with different specificities against cytokeratins. An immunohistochemical study of normal tissues and tumors. Am J Pathol. 1984 Jan;114(1):9–17. [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES